• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用阿育吠陀治疗方式管理的弥漫性系统性硬化症——病例报告

Diffuse systemic sclerosis managed with ayurvedic treatment modalities - A case report.

作者信息

Pandit Ranjani Karthik

机构信息

S. N. Pandit Ayurvedic Company Pvt Ltd, 183, S. N. Pandit Street, old Agrahara, Mysore, 570004, India.

出版信息

J Ayurveda Integr Med. 2025 Jul-Aug;16(4):100883. doi: 10.1016/j.jaim.2023.100883. Epub 2024 May 17.

DOI:10.1016/j.jaim.2023.100883
PMID:38760244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12368285/
Abstract

Diffuse systemic sclerosis or scleroderma is a chronic connective tissue disorder involving many systems and visceral organs. The association of interstitial lung disease carries high mortality risk. This is a case report of a patient aged 25-years, who was diagnosed as diffuse systemic sclerosis, a disease complex along with Interstitial Lung Disease (ILD), sclerodactyly. She also presented with digital ulcers and calcium deposits in the ulcers. The symptomatology was understood by analysing the dosha predominance and the composition of the different qualities of each dosha in the patient. This complicated case with a bad prognosis was managed with Ayurvedic treatment procedures and medicines. Matrabasti (medicated enema) with mahamasha taila and dhanvantara taila was given. yogabasti with dashamoola ksheera paka, dhanvantara taila and madhu (decoctive enema), along with other palliative medicines like rasna yoga raja, Yogendra rasa, vasakasava, drakshadi paka, kaishora guggulu, raktapachakaghana vati and Mahatiktaka ghrita were given to the patient. After 1-1.2 years of continuous treatments, patient started showing gradual changes in her health condition. Relief from joint pains, intake of normal food, weight gain, re-establishment of menstruation, healing of ulcers was some of the changes seen in the patient. This case report summaries the effective management of diffuse systemic sclerosis after deducing the complex disease structure to dosa and guna involved and treated by adopting ayurvedic medicine and treatment procedures.

摘要

弥漫性系统性硬化症或硬皮病是一种累及多个系统和内脏器官的慢性结缔组织疾病。间质性肺病与之相关会带来较高的死亡风险。这是一例25岁患者的病例报告,该患者被诊断为弥漫性系统性硬化症,这是一种伴有间质性肺病(ILD)、硬皮病的复杂疾病。她还出现了指端溃疡以及溃疡处的钙质沉积。通过分析患者体内的主导体液以及各体液不同性质的构成来理解其症状表现。这例预后不良的复杂病例采用阿育吠陀治疗方法和药物进行处理。给予患者用摩诃摩沙油和檀凡陀罗油进行的药浴灌肠(matrabasti)。给予患者用十味草药煎剂、檀凡陀罗油和蜂蜜进行的联合药浴灌肠(yogabasti),以及其他缓解药物,如拉斯纳瑜伽王、约根陀罗配方药、瓦萨卡药酒、葡萄煎剂、凯索拉古古勒、清肝凉血丸和大蒂卡酥油。经过1至1.2年的持续治疗,患者的健康状况开始逐渐出现变化。关节疼痛缓解、能正常进食、体重增加、月经恢复、溃疡愈合等都是在该患者身上看到的一些变化。本病例报告总结了在将复杂的疾病结构推导为所涉及的体液和性质后,采用阿育吠陀药物和治疗方法对弥漫性系统性硬化症进行的有效管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ed/12368285/4a899c7ef8bc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ed/12368285/7a94b4bf8b8a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ed/12368285/4a899c7ef8bc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ed/12368285/7a94b4bf8b8a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ed/12368285/4a899c7ef8bc/gr2.jpg

相似文献

1
Diffuse systemic sclerosis managed with ayurvedic treatment modalities - A case report.采用阿育吠陀治疗方式管理的弥漫性系统性硬化症——病例报告
J Ayurveda Integr Med. 2025 Jul-Aug;16(4):100883. doi: 10.1016/j.jaim.2023.100883. Epub 2024 May 17.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The effectiveness of ayurvedic oil-based nasal instillation (Nasya) medicines in the treatment of facial paralysis (Ardita): a systematic review.阿育吠陀油基滴鼻剂(Nasya)药物治疗面瘫(Ardita)的有效性:一项系统评价。
JBI Database System Rev Implement Rep. 2016 Apr;14(4):198-228. doi: 10.11124/JBISRIR-2016-2402.
4
Long-term disease-free survival of a patient diagnosed with peri-ampullary carcinoma treated with adjunct Ayurvedic treatment - A case report.一名经辅助阿育吠陀疗法治疗的壶腹周围癌患者的长期无病生存——病例报告
J Ayurveda Integr Med. 2025 Sep-Oct;16(5):101111. doi: 10.1016/j.jaim.2024.101111. Epub 2025 Aug 23.
5
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study.预测系统性硬化症相关间质性肺病进展患者后续病情进展的风险:一项多中心观察性队列研究。
Lancet Rheumatol. 2025 Jul;7(7):e463-e471. doi: 10.1016/S2665-9913(25)00026-8. Epub 2025 May 14.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
10
Ayurvedic Management of Presbycusis (Project TOPMAC): Protocol for an Exploratory Randomized Controlled Trial. Ayurvedic 管理 Presbycusis(TOPMAC 项目):探索性随机对照试验方案。
JMIR Res Protoc. 2024 Sep 23;13:e55089. doi: 10.2196/55089.